Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplivanserin versus lormetazepam for chronic primary insomnia with sleep maintenance difficulties
2007-003822-28Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary insomnia comparing Eplivanserin with Lormetazepam (2 arms). Primary endpoint: Morning sleepiness. Started Jan 2008; status: completed.
02
Drugs
eplivanserinlormetazepam
03
Conditions
primary insomnia
Beyond the preview
Go deeper on 2007-003822-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003822-28.